Stirling, UK, 23rd March 2017 – eClinicalHealth Limited, an eClinical technology company offering Clinpal™ the cloud based direct to patient research platformTM, has finished the third round of investment with the sale of Series C shares. The issue closed on the 1st February and raised over GBP2.6million in capital for the company. This places eClinicalHealth in a strong position going forward into 2017 coupled with a strengthening pipeline of business.
In addition to the strong financial position the board have welcomed two new members to build more depth and experience to guide the company forwards.
“We could not be more pleased about the addition of Bill Louv and Jürgen Bauer to our board of directors. Both bring a deep knowledge of the industries we are operating in, as well as, a broad perspective on global business and experience working with growth companies that will be immensely valuable to eClinicalHealth in the years ahead,” says Karl Landert CEO of eClinicalHealth
Bill Louv has joined the board of directors as a non-executive director from the 1st December 2016. Bill comes to the eClinicalHealth bringing over 30 years’ experience working in the Pharmaceutical industry. He brings to the board significant management experience as a member of GSK’s Corporate Executive Team, CIO and Head of Shared Services. Bill now advises a portfolio of next generation Bio-Technology companies assisting with technical oversight, product roadmaps and marketing strategy. As part of his board duties Bill is heading a technical oversight committee.
Jürgen Bauer has joined the board of directors as an investor director from the 26th January 2017. With over 25 years’ experience in management consulting services. He was co-founder of Lodestone Management Consultants and Partner in PwC, IBM and Infosys. Currently Jürgen is working as a member of a number of executive boards including NLS Pharma AG and Scantrust advising on strategy and growth. Jürgen’s executive management experience brings a depth of knowledge of corporate governance and business development which will be part of the foundation for growth within eClinicalhealth.
About eClinicalHealth Limited
Headquartered in Scotland, eClinicalHealth Limited, developers of the revolutionary ClinpalTM direct to patient research platform, was founded in early 2012. The company is committed to leading open and collaborative innovation discussions about remote clinical trial processes and technology with pharmaceutical companies, CROs and other service and technology providers.